A panel of experts will assemble next week to discuss the ethics of using experimental treatments for Ebola during the current outbreak in West Africa, according to the World Health Organization.
A panel of experts will assemble next week to discuss the ethics of using experimental treatments for Ebola during the current outbreak in West Africa, according to the World Health Organization.
The 'experimental serum' that doctors gave to two American patients who contracted Ebola is in very limited supply, and it will not be available for general use, according to the Centers for Disease Control and Prevention.
Giving experimental treatments to patients infected with Ebola in West Africa is, indeed, the ethical thing to do, even though the risks and benefits of these treatments are unknown, a panel of experts has decided.
There is no approved treatment for the Ebola virus, but that hasn't stopped online dealers from offering products claiming to prevent the virus or treat people who have the infection.
The outbreak of Ebola virus disease that has claimed more than 1,000 lives in West Africa this year poses a serious, ongoing threat to that region: the spread to capital cities and Nigeria -- Africa's most populous nation -- presents new challenges for healthcare professionals. The situation has garnered significant attention and fear around the world, but proven public health measures and sharpened clinical vigilance will contain the epidemic and thwart a global spread.
An experimental nano silver medication that Nigeria is planning to give to Ebola patients is unlikely to work.
The World Health Organization says the crisis has been vastly underestimated. Continue reading
Dr. Kent Brantly, an American doctor who contracted the Ebola virus in West Africa, is cured of the disease and was released today from Emory University Hospital in Atlanta.
Experience with Ebola survivors in Africa suggests that the two American Ebola patients who recovered from the disease are now immune to the strain of the virus that infected them.
There are currently 1 users browsing this thread. (0 members and 1 guests)